PHASTAR, a global CRO, will establish new offices in Tokyo and the West Coast of North America in 2020, which will serve as operational hubs for customers in Japan and western North America. The company is currently recruiting staff for the new offices.
 
Kevin Kane, PHASTAR chief executive officer, said, “I am delighted to be adding these key locations to our existing presence across Europe, the eastern U.S., Kenya, and Australia. We want to attract the best talent possible into PHASTAR and opening offices in these regions gives us access to more experts well-versed in clinical study design and reporting. We have chosen locations that are close to existing customers, and senior staff in the new sites will continue to enhance our customer interface. PHASTAR is one year into a strategic plan, which is delivering growth of which we’re very proud.  Tokyo and the west coast are coming on stream at a good time for us and will support us in our vision to become a supplier of choice to the pharma and biotech sectors.”